SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (23878)6/4/2007 12:47:18 PM
From: dr.praveen  Read Replies (1) | Respond to of 52153
 
SGXP selected 523 as it's lead cpd for CMET program which is good news. Supposed to enter clinic in 1Q,08. Still some time to go and uncertainity like it's BCR-ABL program. I think any big pharma partnership this summer like Novacea will lift the stock.



To: Biomaven who wrote (23878)6/4/2007 1:02:00 PM
From: Casaubon  Respond to of 52153
 
CMET

cancerres.aacrjournals.org
methylgene.com